Goutam Chakraborty

Assistant Professor

Icahn School of Medicine at Mount Sinai

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Goutam Chakraborty is an Assistant Professor at the Icahn School of Medicine at Mount Sinai, located in the United States. His research focuses on prostate cancer, exploring areas such as tumor heterogeneity, epigenetic mechanisms, and molecular imaging. Dr. Chakraborty has published articles investigating the impact of genetic factors on cancer outcomes and the therapeutic potential of various signaling pathways.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Hyunho Han

Yonsei University College of Medicine

SOUTH KOREA

View details

Mohammad Atiq

University of California Davis Comprehensive Cancer Center

UNITED STATES

View details

Zachary Samuels

The Graduate Center, CUNY

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Goutam Chakraborty

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting.

SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.

Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer.

Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3

Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis

Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer.

The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer

Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.

Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors

A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.

Collaborators (3)

Hyunho Han

Mohammad Atiq

Zachary Samuels

Make your next move.